Founded in 1948, CDC Group is a Development Finance Institution and is wholly owned by the UK government. CDC's mission is to support the building of businesses throughout Africa and South Asia, to create jobs and to make a lasting difference in the lives of people who live in some of the world's poorest areas.
Foresight Group is an alternative asset manager with a strong 30-year track record and specific expertise in environmental and solar infrastructure and private equity.
Foresight Group is a leading independent infrastructure and private equity investment manager which has been managing investment funds on behalf of institutions and retail clients for 30 years.
With current assets under management of over £2.2 billion, raised from the UK and international private and high-net-worth individuals, family offices, pension funds and other institutional investors, Foresight strives to generate increasing dividends and capital appreciation for its investors over the long term.
Foresight has offices in UK, USA, Italy, and Australia.
Founder Collective is a seed-stage venture capital fund, built by a collection of successful entrepreneurs. The firm is headquartered in New York City and Cambridge, but makes investments all over the world. With $50M under management, the fund is focused on East coast investments. Founder Collective is industry agnostic, but the firm prefers companies that have an information technology component.
Magnum Capital is a private equity firm that invests in mid-to-upper middle market Iberian companies. It targets companies with significant value creation potential.
Magnum Capital systematically conducts a detailed due diligence exercise before any investment decision is approved. It was founded in 2006 and is headquartered in Madrid, Spain.
Wellington Management Company is a Boston based institutional investment advisor firm. The firm invests in global equity, fixed income, currency and commodity markets, multi-strategy, specialty and alternative investments. The firm offers separate accounts and a wide range of commingled vehicles that include both US and non-US domiciled portfolios. The company was founded in 1928.
MASSACHUSETTS CAPITAL RESOURCE COMPANY was established in 1977 as a limited partnership privately owned and funded by Massachusetts-based life insurance companies. The Company’s mission was to create a source of risk capital to fill the senior debt to equity funding “gap” experienced by growing companies. Their investment activity complements, rather than competes with, the financing provided by senior lenders and equity investors. Mass. Capital provides higher risk growth and acquisition capital to manufacturing, distribution, service and technology companies. They focus on emerging growth and middle market companies with operations in Massachusetts. Their investments are structured to fit the specific needs of portfolio companies and to complement funding available from senior lenders and equity investors.
Founded in 1999, Enhanced Capital Partners is a national investment firm with over $400 million under management specializing in investments in small and mid-size companies.
Enhanced Capital provides a range of investment options to promote the growth and expansion of businesses. Our flexibility and practical investment approach can make the difference in maximizing the growth potential for a company poised for rapid growth.
Full Investment Portfolio
Liquid and sub-20% listed asset 36%
Liquid large blocs (between 20% and 50% share) 10%
Listed large blocs (over 50% share) 12%
Unlisted assets 42%
Founded in 1974 to hold Singapore government investments in various businesses, Temasek is an active shareholder in a broad range of industries, ranging from transportation and logistics, to finance, telecommunications, engineering and property. Its portfolio comprises cash, fixed income, equities, absolute returns strategies and private equity funds.
Goldman Sachs Investment Partners is a global team of professionals from a wide range of backgrounds with one common goal—driving technology-based disruption. They have invested more than $6 billion in over 100 late-stage venture capital and growth equity transactions since 2003. They are dedicated to partnering with entrepreneurs around the world to build revolutionary businesses.
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicated efforts bring significant financial support to Mayo's patient care, education and research efforts.